R2053509 |
DOTA-TOC |
|
R2053510 |
Foxy-5 |
Foxy-5, a WNT5A agonist, is a mimicking peptide of WNT5A which is a non-canonica
|
R2053511 |
SPR-741;SPR741 (NAB741) |
SPR741 (NAB741) is a cationic peptide derived from polymyxin B and is a potentia
|
R2053512 |
SR59230A |
SR59230A is a potent, selective, and blood-brain barrier penetrating β3-adrenerg
|
R2053513 |
ADH-1 trifluoroacetate |
ADH-1 trifluoroacetate is an N-cadherin antagonist, which inhibits N-cadherin me
|
R2053514 |
ADH-1 |
ADH-1, an N-cadherin antagonist, inhibits N-cadherin mediated cell adhesion.
|
R2053515 |
Aripiprazole Lauroxil |
Aripiprazole lauroxil, an N-acyloxymethyl prodrug of aripiprazole, is a Long-act
|
R2053516 |
DCBA |
DCBA is a metabolite of insect repellent N-N-diethyl-meta-toluamide (DEET). The
|
R2053517 |
Dovitinib Lactate |
Dovitinib lactate (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor
|
R2053518 |
NVP-2 |
NVP-2 is a potent and selective ATP-competitive cyclin dependent kinase 9 (CDK9)
|
R2053519 |
HLM006474 |
HLM006474 is a pan E2F inhibitor, which inhibits E2F4 DNA-binding with an IC50 o
|
R2053520 |
Bindarit (AF2838) |
Bindarit (AF2838) is a selective inhibitor of the monocyte chemotactic proteins
|
R2053521 |
9-ING-41 |
9-ING-41 is a potent glycogen synthase kinase-3 (GSK-3) inhibitor. 9-ING-41 indu
|
R2053522 |
GDC-046 |
GDC-046 is a potent, selective, and orally bioavailable TYK2 inhibitor with Kis
|
R2053523 |
Compound Y-1 |
Compound Y-1 exerts the best inhibition activity (IC50= 0.21 μM) against NA, whi
|
R2053524 |
Fedratinib hydrochloride hydrate (TG-101348 hydrochloride hydrate) |
Fedratinib hydrochloride hydrate (TG-101348 hydrochloride hydrate) is a potent,
|
R2053525 |
(±)-BAY-1251152 |
(±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is a potent and
|
R2053526 |
EX229 |
EX229, a Benzimidazole derivative, is a potent and allosteric activator of AMP-a
|
R2053527 |
Autogramin-1 |
Autogramin-1 potently inhibits autophagy induced by either starvation (IC50=0.17
|
R2053528 |
Encequidar mesylate (HM30181 mesylate; HM30181A mesylate) |
Encequidar mesylate (HM30181 mesylate; HM30181A mesylate) is a competitive and p
|
R2053529 |
Inarigivir (ORI-9020;SB-9000) |
Inarigivir (ORI-9020;SB-9000) is a dinucleotide which can significantly reduce l
|
R2053530 |
PF02341066 hydrochloride |
Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable,
|
R2053531 |
Hydrazinium hydroxide |
|
R2053532 |
Eravacycline dihydrochloride (TP-434 dihydrochloride) |
Eravacycline dihydrochloride (TP-434 dihydrochloride) is a potent and broad-spec
|
R2053533 |
PF-06873600 |
PF-06873600 is a selective and orally bioavailable inhibitor of cyclin-dependent
|